Usa Financial Portformulas Corp Dexcom Inc Transaction History

Usa Financial Portformulas Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$110.31 - $140.45 $958,262 - $1.22 Million	8,687 New	8,687 $984,000
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $301 - $496	-4 Reduced 3.81%	101 $12,000
Q3 2023 Nov 27, 2023	BUY	$86.06 - $137.93 $8,692 - $13,930	101 Added 2525.0%	105 $9,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $203 - $398	3 Added 300.0%	4 $0
Q1 2022 Aug 16, 2022	BUY	$94.08 - $130.2 $94 - $130	1 New	1 $1,000
Q4 2020 Jan 29, 2021	SELL	$78.0 - $104.5 $487,890 - $653,647	-6,255 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$95.51 - $112.95 $459,976 - $543,967	-4,816 Reduced 43.5%	6,255 $2.58 Million
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $526,135 - $884,223	8,394 Added 313.56%	11,071 $4.49 Million
Q1 2020 Apr 13, 2020	BUY	$47.79 - $75.63 $99,212 - $157,007	2,076 Added 345.42%	2,677 $721,000
Q4 2019 Feb 07, 2020	BUY	$36.62 - $57.29 $22,008 - $34,431	601 New	601 $131,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $213 - $262	-6 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $168 - $229	6 New	6 $1,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.